Recall Register

Device recall: BD Recanalization System, REF: BDRECANSYSTEM

Class II FDA enforcement event 93607. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Recanalization systems may be in a manufacturing mode that allows the system to continuously run without the typical 30 second pauses, and 4-minute warning/5-minute restart required messages to indicate the ten-minute maximum catheter use time has been exceeded, which may increase the risk of the device overheating or breaking.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Bard Peripheral Vascular Inc started this device recall on 14 Nov 2023. The firm address in the FDA record is in Tempe, AZ. FDA put the recall in Class II. FDA event 93607 has 1 product record. The first FDA enforcement report date is 17 Jan 2024. The record gives the status Ongoing. 340 of the 917 device events that started in 2023 have more product records. The median device event of 2023 has 1 product record. The openFDA file has 917 device events that started in 2023 and 839 that started in 2022.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US: CA, OH, PA, NY, TX, NJ, MS, IL, GA, AL, AZ, NC, NV, PR, IN, MA, WI, KS, AR, FL, MD, IA, NE, LA, HI, MO, DE, DC, VA, NM, CO, KY, ME, MN

Recalling firm

Bard Peripheral Vascular Inc, Tempe, AZ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 93607: product records
Recall numberProductQuantityClassStatusReport date
Z-0676-2024BD Recanalization System, REF: BDRECANSYSTEM403Class IIOngoing17 Jan 2024

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2023
917
Share of these events in Class II
88%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
57

Other events of the firm

Other FDA enforcement events of Bard Peripheral Vascular Inc
InitiatedProduct (first record)TypeClassRecords
20 Aug 2026EnCor EnCompass Breast Biopsy and Tissue Removal System Console (model number: ENCPCONSOLE) and Driver (model number: ENDeviceClass II1
12 Dec 2025Broviac 4.2 Fr Single-Lumen CV Catheter Cutdown Tray with SureCuff Tissue Ingrowth Cuff Cat 60060DeviceClass II1
6 Nov 2025Safe-T-Centesis 6 Fr Catheter Drainage Tray, REF: PIG1260T,DeviceClass II1
21 Aug 2025Venclose digiRF Generators, Model VCRFG1, with software 3.35 designed to identify internal wiring anomalies in the VenclDeviceClass II1
5 Feb 2025Rotarex Atherectomy System and Instructions for Use, BD SET Rotarex: S 6 F x 110 cm, REF: 80236; S 6 F x 135 cm, REF: 80DeviceClass I1
30 Sep 2024Bard Marquee Disposable Core Biopsy Instrument Kit: BARD MARQUEE KIT 12G X 10 CM, REF: MQK1210; BARD MARQUEE 12G X 10 CMDeviceClass II1
4 Sep 2024The EVSRF catheter is a sterile, single-use disposable medical device for endovenous radiofrequency ablation, a procedurDeviceClass II1
2 Aug 2024BARD MAGNUM Disposable Core Tissue Biopsy Needle REF: MN1410 MN 1420 MN1610 MN1616 MN1820 MN2010 The Magnum Biopsy SysteDeviceClass II1
10 Jul 2024Guidewire 70cm x 1mm (0.038 ) REF 5583705 These accessories are intended for use with Bard 14.5 Fr. Long-Term Dual LumenDeviceClass II1
8 Nov 2023Bard Mission Disposable Core Biopsy Instrument Kit (REF/Name): 1410MSK/ Mission Kit 14G x 10CM; 1416MSK/ Mission Kit 14GDeviceClass II1

Bard Peripheral Vascular Inc: all 57 events

Official channels

Cite this page

Recall Register. FDA enforcement event 93607. https://recallregister.com/fda/ii/93607/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US: CA, OH, PA, NY, TX, NJ, MS, IL, GA, AL, AZ, NC, NV, PR, IN, MA, WI, KS, AR, FL, MD, IA, NE, LA, HI, MO, DE, DC, VA, NM, CO, KY, ME, MN
What quantity of product is in FDA event 93607?
The FDA record gives this quantity: 403
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2023 have the same class?
88% of the 917 device events that started in 2023 are in Class II.